MI and Non-obstructive Coronary Arteries

US Cardiol. 2024 Jul 23:18:e10. doi: 10.15420/usc.2023.12. eCollection 2024.

Abstract

MI and non-obstructive coronary arteries (MINOCA) is recognized as an important contributor to adverse cardiovascular outcomes in both men and women but is particularly prevalent in young women. Multiple coronary mechanisms such as coronary plaque disruption, coronary artery spasm, coronary microvascular dysfunction, spontaneous coronary artery dissection, and coronary thromboembolism can trigger MINOCA. Beyond routine left heart catheterization, invasive intracoronary imaging and cardiac MRI can help to clarify the cause of MINOCA. Conditions such as myocarditis, takotsubo syndrome, and cardiomyopathy are on the differential as alternate explanations in those suspected of MINOCA. Identification of the underlying cause in a case of MINOCA has therapeutic implications. While long-term management of MINOCA is not standardized, angiotensin converting enzyme inhibitors and statins appear to be of benefit. In this review, we discuss the prevalence and pathophysiology of MINOCA, diagnostic considerations, and current treatment approaches to manage this high-risk group of patients.

Keywords: MINOCA; Myocardial infarction and non-obstructive coronary arteries; high-sensitivity troponin; vasospasm; women.

Publication types

  • Review

Grants and funding

This work was supported in part by the NIH grants R01HL157311, and Specialized Center of Research Excellence in Sex Differences (SCORE) 1U54AG062334-01. YAF is supported by the Stimulating Access to Research in Residency of the NIH (R38AI140299). We also thank Marcia Taylor for her support.